IBC Pharmaceuticals gets Orphan Drug designation

IBC (Morris Plains, N.J.) received Orphan Drug designation for Pentacea to treat small cell lung cancer. IBC is a joint venture between Immunomedics (IMMU) and Beckman Coulter (BEC). Pentacea, a bispe...